| CAS ID: | 135062-02-1 |
| Molecular Formula: | C27H36N2O4 |
| Molecular Weight: | 452.6 g/mol |
| Monoisotopic Mass: | 452.2675 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | ENYGLID | Prandin | NOVONORM | AG-EE 623 ZW | AGEE-623ZW | REPAGLINIDE |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1 | See All |
| InChI Key: | FAEKWTJYAYMJKF-QHCPKHFHSA-N | |
| Smiles: | CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3)ccc1C(=O)O | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00662714 | Disease | Cystic fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | April 21, 2008 | Last Verified | July 10, 2012 |
| Sponsor | Mukoviszidose Institut gGmbH | ||
Trial Record 2
| ClinicalTrial ID | NCT00763412 | Disease | Cystic fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | October 1, 2008 | Last Verified | June 5, 2017 |
| Sponsor | Arbelaez, Ana Maria | ||
Trial Record 3
| ClinicalTrial ID | NCT00231192 | Disease | Cystic fibrosis |
| Phase | Not Applicable | Status | Withdrawn |
| First Received | October 4, 2005 | Last Verified | March 12, 2015 |
| Sponsor | Children's Hospital of Philadelphia | ||
| PubChem: | 65981 |
| ChEMBL: | CHEMBL1272 |